Immunitybio Inc (IBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -129,666 | -413,645 | -354,466 | -268,714 | -134,130 |
| Depreciation Amortization | 3,777 | 40,141 | 30,996 | 20,342 | 9,613 |
| Accounts receivable | -14,669 | -2,360 | -4,175 | -1,033 | 0 |
| Accounts payable and accrued liabilities | 6,439 | -3,167 | 47 | 8,969 | 4,314 |
| Other Working Capital | -22,035 | -19,422 | -8,580 | 1,470 | -3,893 |
| Other Operating Activity | 70,249 | 7,217 | 30,086 | 31,637 | 17,114 |
| Operating Cash Flow | $-85,905 | $-391,236 | $-306,092 | $-207,329 | $-106,982 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -100 | -140,218 | -134,129 | -134,129 | -48,363 |
| PPE Investments | -1,121 | -6,888 | -4,777 | -1,985 | -1,261 |
| Net Acquisitions | N/A | -1,000 | -1,000 | N/A | N/A |
| Sale Of Investment | 5,350 | 136,607 | 118,573 | 49,002 | 14,002 |
| Other Investing Activity | 0 | -747 | -747 | 0 | 0 |
| Investing Cash Flow | $4,129 | $-12,246 | $-22,080 | $-87,112 | $-35,622 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | -64 | -64 | -42 | -21 |
| Common Stock Issued | 220 | 190,203 | 82,471 | 66,568 | 14,116 |
| Other Financing Activity | -1,202 | 91,491 | 92,294 | 92,593 | -3,870 |
| Financing Cash Flow | $-982 | $281,630 | $174,701 | $159,119 | $10,225 |
| Exchange Rate Effect | -10 | -23 | -16 | -27 | -39 |
| Beginning Cash Position | 143,912 | 265,787 | 265,787 | 265,787 | 265,787 |
| End Cash Position | 61,144 | 143,912 | 112,300 | 130,438 | 133,369 |
| Net Cash Flow | $-82,768 | $-121,875 | $-153,487 | $-135,349 | $-132,418 |
| Free Cash Flow | |||||
| Operating Cash Flow | -85,905 | -391,236 | -306,092 | -207,329 | -106,982 |
| Capital Expenditure | -1,121 | -6,888 | -4,777 | -1,985 | -1,261 |
| Free Cash Flow | -87,026 | -398,124 | -310,869 | -209,314 | -108,243 |